Work

TLC388, a novel topoisomerase-1 inhibitor with antihypoxia inducible factor-1 alpha activity: A phase I and pharmacokinetic study in patients with advanced solid malignancies.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.e13020

Authors: C. Lin, S. A. Ghamande, B. J. Dezube, M. H. Silverman, K. Fong, M. Kuo, W. Mach, Y. Tseng, S. Hsu, S. Goel

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2246810835

Cites:

Cited by:

Related to: 10